Literature DB >> 31760971

The CORE Group Polio Project: An Overview of Its History and Its Contributions to the Global Polio Eradication Initiative.

Lee Losey1, Ellyn Ogden2, Filimona Bisrat3, Roma Solomon4, David Newberry1, Ellen Coates1, Dora Ward1, Lisa Hilmi5, Karen LeBan5, Vanessa Burrowes6, Henry B Perry6.   

Abstract

The CORE Group Polio Project (CGPP) has contributed to polio eradication by successfully engaging civil society, particularly the non-governmental organization (NGO) community. This engagement, which began with a grant from the U.S. Agency for International Development in 1999, has contributed to improvements in routine immunization programs, polio campaign quality, and surveillance for acute flaccid paralysis in many challenging geographic areas. The CGPP has worked closely with polio eradication partners in a collaborative and supportive role. The CGPP has focused largely on high-risk areas with marginalized or hard-to-reach populations where health systems and immunization programs have also been weak and where transmission of poliovirus had not been stopped. The CGPP has engaged local civic leaders and communities in ways to complement top-down vertical efforts of ministries of health and other partners in the Global Polio Eradication Initiative. The CGPP has developed innovative strategies to detect cases using community-based surveillance, promoted independent campaign monitoring, established cross-border initiatives, and developed a strong and creative cadre of community mobilizers to track missed children and deliver behavior change education. Many of the innovations and approaches that the CGPP helped to develop are now being replicated by governments and international agencies to tackle other public health priorities in underserved and marginalized communities around the world. This article is the first in a series of articles describing the work of the CGPP. Because the article describes the work of more than 40 NGOs in 11 countries over 20 years, it provides only an overview, leaving many important details and variations of the CGPP's work to be described elsewhere, including in other articles included in this series.

Entities:  

Mesh:

Year:  2019        PMID: 31760971      PMCID: PMC6776098          DOI: 10.4269/ajtmh.18-0916

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

Review 1.  Polio eradication from the Western Hemisphere.

Authors:  C A de Quadros; J K Andrus; J M Olive; C Guerra de Macedo; D A Henderson
Journal:  Annu Rev Public Health       Date:  1992       Impact factor: 21.981

2.  Deconstructing social resistance to pulse polio campaign in two North Indian districts.

Authors:  Sanjay Chaturvedi; Rajib Dasgupta; Vivek Adhish; Kalyan K Ganguly; Sanjay Rai; Leena Sushant; S Srabasti; Narendra K Arora
Journal:  Indian Pediatr       Date:  2009-09-03       Impact factor: 1.411

3.  Acute flaccid paralysis surveillance status and community awareness in pastoralist and semi-pastoralist communities of Ethiopia.

Authors:  Kibrom Abraham; Filimona Bisrat; Mesganaw Fantahun; Muluken Asres; Legesse Kidane; Bezunesh Rogie
Journal:  Ethiop Med J       Date:  2013-07

4.  Linking community volunteer surveillance focal persons with health extension workers on polio surveillance.

Authors:  Bezunesh Dinku; Abera Kumie; Filimona Bisrat
Journal:  Ethiop Med J       Date:  2013-07

Review 5.  Global polio eradication initiative: lessons learned and legacy.

Authors:  Stephen L Cochi; Andrew Freeman; Sherine Guirguis; Hamid Jafari; Bruce Aylward
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

6.  Outcomes of polio eradication activities in Uttar Pradesh, India: the Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP).

Authors:  William M Weiss; M H Rahman; Roma Solomon; Vibha Singh; Dora Ward
Journal:  BMC Infect Dis       Date:  2011-05-10       Impact factor: 3.090

7.  Successful polio eradication in Uttar Pradesh, India: the pivotal contribution of the Social Mobilization Network, an NGO/UNICEF collaboration.

Authors:  Ellen A Coates; Silvio Waisbord; Jitendra Awale; Roma Solomon; Rina Dey
Journal:  Glob Health Sci Pract       Date:  2013-03-21

8.  Performance and determinants of routine immunization coverage within the context of intensive polio eradication activities in Uttar Pradesh, India: Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP).

Authors:  William M Weiss; Manojkumar Choudhary; Roma Solomon
Journal:  BMC Int Health Hum Rights       Date:  2013-05-16

9.  Determinants of performance of supplemental immunization activities for polio eradication in Uttar Pradesh, India: social mobilization activities of the Social mobilization Network (SM Net) and Core Group Polio Project (CGPP).

Authors:  William M Weiss; M D Hafizur Rahman; Roma Solomon; Dora Ward
Journal:  BMC Infect Dis       Date:  2013-01-17       Impact factor: 3.090

10.  Assessing the effectiveness of house-to-house visits on routine oral polio immunization completion and tracking of defaulters.

Authors:  Dora Ward Curry; Henry B Perry; Syed N Tirmizi; Allison L Goldstein; Meg C Lynch
Journal:  J Health Popul Nutr       Date:  2014-06       Impact factor: 2.000

  10 in total
  4 in total

Review 1.  People-centred surveillance: a narrative review of community-based surveillance among crisis-affected populations.

Authors:  Ruwan Ratnayake; Meghan Tammaro; Amanda Tiffany; Anine Kongelf; Jonathan A Polonsky; Amanda McClelland
Journal:  Lancet Planet Health       Date:  2020-10

Review 2.  Overcoming vaccine deployment challenges among the hardest to reach: lessons from polio elimination in India.

Authors:  Alejandra Bellatin; Azana Hyder; Sampreeth Rao; Peter Chengming Zhang; Anita M McGahan
Journal:  BMJ Glob Health       Date:  2021-04

3.  The Critical Role and Evaluation of Community Mobilizers in Polio Eradication in Remote Settings in Africa and Asia.

Authors:  Judy Lewis; Karen LeBan; Roma Solomon; Filimona Bisrat; Samuel Usman; Ahmed Arale
Journal:  Glob Health Sci Pract       Date:  2020-09-30

4.  Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.

Authors:  Ze-Jun Wang; Hua-Jun Zhang; Jia Lu; Kang-Wei Xu; Cheng Peng; Jing Guo; Xiao-Xiao Gao; Xin Wan; Wen-Hui Wang; Chao Shan; Su-Cai Zhang; Jie Wu; An-Na Yang; Yan Zhu; Ao Xiao; Lei Zhang; Lie Fu; Hao-Rui Si; Qian Cai; Xing-Lou Yang; Lei You; Yan-Ping Zhou; Jing Liu; De-Qing Pang; Wei-Ping Jin; Xiao-Yu Zhang; Sheng-Li Meng; Yun-Xia Sun; Ulrich Desselberger; Jun-Zhi Wang; Xin-Guo Li; Kai Duan; Chang-Gui Li; Miao Xu; Zheng-Li Shi; Zhi-Ming Yuan; Xiao-Ming Yang; Shuo Shen
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.